Ferrari AC, Chen YH, Rodriguez R, Hudes GR, et al. Phase II Randomized Study of MK-2206 and Bicalutamide in Prostate Cancer Patients With Rising PSA After Primary Therapy (ECOG-ACRIN E2809). Prostate 2026 Jan 29. doi: 10.1002/pros.70125.
PMID: 41609418